{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:03:04Z","timestamp":1784642584744,"version":"3.55.0"},"reference-count":139,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Antibiotics underpin the \u2018modern medicine\u2019 that has increased life expectancy, leading to societies with sizeable vulnerable elderly populations who have suffered disproportionately during the current COVID-19 pandemic. Governments have responded by shuttering economies, limiting social interactions and refocusing healthcare. There are implications for antibiotic resistance both during and after these events. During spring 2020, COVID-19-stressed ICUs relaxed stewardship, perhaps promoting resistance. Counterpoised to this, more citizens died at home and total hospital antibiotic use declined, reducing selection pressure. Restricted travel and social distancing potentially reduced community import and transmission of resistant bacteria, though hard data are lacking. The future depends on the vaccines now being deployed. Unequivocal vaccine success should allow a swift return to normality. Vaccine failure followed by extended and successful non-pharmaceutical suppression may lead to the same point, but only after some delay, and with indefinite travel restrictions; sustainability is doubtful. Alternatively, failure of vaccines and control measures may prompt acceptance that we must live with the virus, as in the prolonged 1889\u201394 \u2018influenza\u2019 (or coronavirus OC43) pandemic. Vaccine failure scenarios, particularly those accepting \u2018learning to live with the virus\u2019, favour increased outpatient management of non-COVID-19 infections using oral and long t\u00bd antibiotics. Ultimately, all models\u2014except those envisaging societal collapse\u2014suggest that COVID-19 will be controlled and that hospitals will revert to pre-2020 patterns with a large backlog of non-COVID-19 patients awaiting treatment. Clearing this will increase workloads, stresses, nosocomial infections, antibiotic use and resistance. New antibiotics, including cefiderocol, are part of the answer. The prescribing information for cefiderocol is available at: https:\/\/shionogi-eu-content.com\/gb\/fetcroja\/pi.<\/jats:p>","DOI":"10.1093\/jacamr\/dlab052","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T11:21:21Z","timestamp":1617189681000},"page":"i5-i16","source":"Crossref","is-referenced-by-count":34,"title":["Antibiotic resistance during and beyond COVID-19"],"prefix":"10.1093","volume":"3","author":[{"given":"David M","family":"Livermore","sequence":"first","affiliation":[{"name":"Norwich Medical School, University of East Anglia, Norwich, Norfolk NR4 7TJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"key":"2021082617410314700_dlab052-B1","year":"2012"},{"key":"2021082617410314700_dlab052-B2","year":"2017"},{"key":"2021082617410314700_dlab052-B3","year":"2017"},{"key":"2021082617410314700_dlab052-B4"},{"key":"2021082617410314700_dlab052-B5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2307\/4590060","article-title":"Influenza vaccine","volume":"73","author":"Smadel","year":"1958","journal-title":"Public Health Rep"},{"key":"2021082617410314700_dlab052-B6","author":"Cyranoski","year":"2020"},{"key":"2021082617410314700_dlab052-B7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"key":"2021082617410314700_dlab052-B8","year":"2021"},{"key":"2021082617410314700_dlab052-B9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M20-3012","article-title":"Prevalence of asymptomatic SARS-CoV-2 infection","volume":"173","author":"Oran","year":"2020","journal-title":"Ann Intern Med"},{"key":"2021082617410314700_dlab052-B10","year":"2019"},{"key":"2021082617410314700_dlab052-B11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2021082617410314700_dlab052-B12","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20\u200a133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"2021082617410314700_dlab052-B13","author":"Williamson","year":"2020"},{"key":"2021082617410314700_dlab052-B14","year":"2020"},{"key":"2021082617410314700_dlab052-B15","doi-asserted-by":"crossref","first-page":"e13423","DOI":"10.1111\/eci.13423","article-title":"Global perspective of COVID-19 epidemiology for a full-cycle pandemic","volume":"50","author":"Ioannidis","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"2021082617410314700_dlab052-B16","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2020.4031","article-title":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"2021082617410314700_dlab052-B17","year":"2020"},{"key":"2021082617410314700_dlab052-B18","year":"2020"},{"key":"2021082617410314700_dlab052-B19","year":"2020"},{"key":"2021082617410314700_dlab052-B20","year":"2021"},{"key":"2021082617410314700_dlab052-B21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-020-2405-7","article-title":"Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe","volume":"584","author":"Flaxman","year":"2020","journal-title":"Nature"},{"key":"2021082617410314700_dlab052-B22","year":"2020"},{"key":"2021082617410314700_dlab052-B23","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3389\/fpubh.2020.604339","article-title":"COVID-19 mortality: a matter of vulnerability among nations facing limited margins of adaptation","volume":"8","author":"De Larochelambert","year":"2020","journal-title":"Front Public Health"},{"key":"2021082617410314700_dlab052-B24","author":"Kepp","year":"2021"},{"key":"2021082617410314700_dlab052-B25","year":"2020"},{"key":"2021082617410314700_dlab052-B26","first-page":"2459","article-title":"Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021082617410314700_dlab052-B27","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2021082617410314700_dlab052-B28","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.jinf.2020.06.056","article-title":"Improving antibiotic stewardship in COVID-19: bacterial co-infection is less common than with influenza","volume":"81","author":"Youngs","year":"2020","journal-title":"J Infect"},{"key":"2021082617410314700_dlab052-B29","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/j.jinf.2020.06.004","article-title":"Early administered antibiotics do not impact mortality in critically ill patients with COVID-19","volume":"81","author":"Buetti","year":"2020","journal-title":"J Infect"},{"key":"2021082617410314700_dlab052-B30","doi-asserted-by":"crossref","first-page":"m2378","DOI":"10.1136\/bmj.m2378","article-title":"Hydroxychloroquine for covid-19: the end of the line?","volume":"369","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"2021082617410314700_dlab052-B31","year":"2020"},{"key":"2021082617410314700_dlab052-B32","article-title":"Organisms causing secondary pneumonias in COVID-19 patients at 5 UK ICUs as detected with the FilmArray test","author":"Dhesi","year":"2020","journal-title":"medRxiv"},{"key":"2021082617410314700_dlab052-B33","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciaa762","article-title":"Bacterial pneumonia in COVID-19 critically ill patients: a case series","volume":"72","author":"Dudoignon","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2021082617410314700_dlab052-B34","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1017\/ice.2020.381","article-title":"Antibiotic prescription during the COVID-19 pandemic: a biphasic pattern","volume":"41","author":"Abelenda-Alonso","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2021082617410314700_dlab052-B35","doi-asserted-by":"crossref","first-page":"e20182491","DOI":"10.1542\/peds.2018-2491","article-title":"Antibiotic prescribing during pediatric direct-to-consumer telemedicine visits","volume":"143","author":"Ray","year":"2019","journal-title":"Pediatrics"},{"key":"2021082617410314700_dlab052-B36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1357633X18793031","article-title":"Treating pediatric conjunctivitis without an exam: an evaluation of outcomes and antibiotic usage","volume":"26","author":"Penza","year":"2020","journal-title":"J Telemed Telecare"},{"key":"2021082617410314700_dlab052-B37","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1377\/hlthaff.2018.05091","article-title":"Quality of care for acute respiratory infections during direct-to-consumer telemedicine visits for adults","volume":"37","author":"Shi","year":"2018","journal-title":"Health Affairs"},{"key":"2021082617410314700_dlab052-B38","year":"2020"},{"key":"2021082617410314700_dlab052-B39","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.ijtb.2020.07.003","article-title":"COVID-19 -Tuberculosis interactions: when dark forces collide","volume":"67 Suppl","author":"Udwadia","year":"2020","journal-title":"Indian J Tuberc"},{"key":"2021082617410314700_dlab052-B40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41415-020-1652-1","article-title":"Prescribing antibiotics for urgent dental care during the pandemic","volume":"228","year":"2020","journal-title":"Br Dent J"},{"key":"2021082617410314700_dlab052-B41","year":"2020"},{"key":"2021082617410314700_dlab052-B42","year":"2020"},{"key":"2021082617410314700_dlab052-B43","year":"2020"},{"key":"2021082617410314700_dlab052-B44","year":"2021"},{"key":"2021082617410314700_dlab052-B45","year":"2020"},{"key":"2021082617410314700_dlab052-B46","year":"2020"},{"key":"2021082617410314700_dlab052-B47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fpubh.2020.00284","article-title":"Ethical criteria for the admission and management of patients in the ICU under conditions of limited medical resources: a shared international proposal in view of the COVID-19 pandemic","volume":"8","author":"Tambone","year":"2020","journal-title":"Front Public Health"},{"key":"2021082617410314700_dlab052-B48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s13054-020-03021-2","article-title":"Admission decisions to intensive care units in the context of the major COVID-19 outbreak: local guidance from the COVID-19 Paris-region area","volume":"24","author":"Azoulay","year":"2020","journal-title":"Crit Care"},{"key":"2021082617410314700_dlab052-B49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijantimicag.2018.03.013","article-title":"Pseudomonas aeruginosa sequence type 357 with VEB extended-spectrum \u03b2-lactamases in the UK: relatedness and resistance","volume":"52","author":"Greenwood","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"2021082617410314700_dlab052-B50","doi-asserted-by":"crossref","first-page":"tav024","DOI":"10.1093\/jtm\/tav024","article-title":"High carriage rate of ESBL-producing Enterobacteriaceae at presentation and follow-up among travellers with gastrointestinal complaints returning from India and Southeast Asia","volume":"23","author":"Barreto Miranda","year":"2016","journal-title":"J Travel Med"},{"key":"2021082617410314700_dlab052-B51","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/AAC.00220-10","article-title":"Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum \u03b2-lactamases: a prospective study with Swedish volunteers","volume":"54","author":"T\u00e4ngd\u00e9n","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021082617410314700_dlab052-B52","doi-asserted-by":"crossref","first-page":"1800323","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323","article-title":"Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018","volume":"23","author":"Eyre","year":"2018","journal-title":"Euro Surveill"},{"key":"2021082617410314700_dlab052-B53","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1473-3099(20)30055-4","article-title":"Lessons learnt from ceftriaxone-resistant gonorrhoea in the UK and Australia","volume":"20","author":"Fifer","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2021082617410314700_dlab052-B54","year":"2020"},{"key":"2021082617410314700_dlab052-B55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/sextrans-2020-054608","article-title":"Trend of main STIs during COVID-19 pandemic in Milan, Italy","volume":"97","author":"Cusini","year":"2021","journal-title":"Sex Transm Infect"},{"key":"2021082617410314700_dlab052-B56","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/aje\/kwv283","article-title":"Relating pneumococcal carriage among children to disease rates among adults before and after the introduction of conjugate vaccines","volume":"183","author":"Weinberger","year":"2016","journal-title":"Am J Epidemiol"},{"key":"2021082617410314700_dlab052-B57","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00431-020-03747-9","article-title":"Incidental lowering of otitis-media complaints in otitis-prone children during COVID-19 pandemic: not all evil comes to hurt","volume":"180","author":"Torretta","year":"2021","journal-title":"Eur J Pediatr"},{"key":"2021082617410314700_dlab052-B58","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1086\/502516","article-title":"Nosocomial acquisition of methicillin-resistant Staphylococcus aureus during an outbreak of severe acute respiratory syndrome","volume":"26","author":"Poutanen","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2021082617410314700_dlab052-B59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2047-2994-1-13","article-title":"Impact of a hospital-wide hand hygiene promotion strategy on healthcare-associated infections","volume":"1","author":"Ling","year":"2012","journal-title":"Antimicrob Resist Infect Control"},{"key":"2021082617410314700_dlab052-B60","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0950268800048019","article-title":"The time course of the immune response to experimental coronavirus infection of man","volume":"105","author":"Callow","year":"1990","journal-title":"Epidemiol Infect"},{"key":"2021082617410314700_dlab052-B61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.12688\/wellcomeopenres.15927.1","article-title":"Antibody testing for COVID-19: a report from the National COVID Scientific Advisory Panel","volume":"5","author":"Adams","year":"2020","journal-title":"Wellcome Open Res"},{"key":"2021082617410314700_dlab052-B62","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"2021082617410314700_dlab052-B63","article-title":"Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection","author":"Zuo","year":"2020","journal-title":"bioRxiv"},{"key":"2021082617410314700_dlab052-B64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","article-title":"Immunosenescence and human vaccine immune responses","volume":"16","author":"Crooke","year":"2019","journal-title":"Immun Ageing"},{"key":"2021082617410314700_dlab052-B65","year":"2019"},{"key":"2021082617410314700_dlab052-B66","doi-asserted-by":"crossref","first-page":"e18790","DOI":"10.2196\/18790","article-title":"Use of rapid online surveys to assess people's perceptions during infectious disease outbreaks: a cross-sectional survey on COVID-19","volume":"22","author":"Geldsetzer","year":"2020","journal-title":"J Med Internet Res"},{"key":"2021082617410314700_dlab052-B67","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/S0264-410X(02)00254-2","article-title":"Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control","volume":"20","author":"Hilleman","year":"2002","journal-title":"Vaccine"},{"key":"2021082617410314700_dlab052-B68","doi-asserted-by":"crossref","first-page":"8778","DOI":"10.1073\/pnas.1000886107","article-title":"Transmissibility and geographic spread of the 1889 influenza pandemic","volume":"107","author":"Valleron","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021082617410314700_dlab052-B69","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/JVI.79.3.1595-1604.2005","article-title":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event","volume":"79","author":"Vijgen","year":"2005","journal-title":"J Virol"},{"key":"2021082617410314700_dlab052-B70","doi-asserted-by":"crossref","first-page":"B6","DOI":"10.1016\/j.vaccine.2011.02.050","article-title":"Age distribution of cases and deaths during the 1889 influenza pandemic","volume":"29 Suppl 2","author":"Valtat","year":"2011","journal-title":"Vaccine"},{"key":"2021082617410314700_dlab052-B71","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1057\/9780230304628_8","volume-title":"Cultures of Care in Irish Medical History, 1750\u20131970","author":"Foley","year":"2010"},{"key":"2021082617410314700_dlab052-B72","volume-title":"A History of Epidemics in Britain from A.D. 664 to the Extinction of Plague","author":"Creighton","year":"1894"},{"key":"2021082617410314700_dlab052-B73","volume-title":"Pandemic Influenza, 1700-1900: A Study in Historical Epidemiology","author":"Patterson","year":"1986"},{"key":"2021082617410314700_dlab052-B74","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41577-020-0389-z","article-title":"Pre-existing immunity to SARS-CoV-2: the knowns and unknowns","volume":"20","author":"Sette","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2021082617410314700_dlab052-B75","author":"Khan","year":"2020"},{"key":"2021082617410314700_dlab052-B76","first-page":"330","article-title":"An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus","volume":"17","author":"Patrick","year":"2006","journal-title":"Can J Infect"},{"key":"2021082617410314700_dlab052-B77","year":"2020"},{"key":"2021082617410314700_dlab052-B78","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.qco.0000136931.83167.d2","article-title":"Nursing resources: a major determinant of nosocomial infection?","volume":"17","author":"Hugonnet","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"2021082617410314700_dlab052-B79","year":"2020"},{"key":"2021082617410314700_dlab052-B80","year":"2020"},{"key":"2021082617410314700_dlab052-B81","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.7861\/clinmed.2020-0839","article-title":"The impact of false positive COVID-19 results in an area of low prevalence","volume":"21","author":"Healy","year":"2021","journal-title":"Clin Med"},{"key":"2021082617410314700_dlab052-B82","doi-asserted-by":"crossref","first-page":"m4787","DOI":"10.1136\/bmj.m4787","article-title":"Lateral flow tests cannot rule out SARS-CoV-2 infection","volume":"371","author":"Deeks","year":"2020","journal-title":"BMJ"},{"key":"2021082617410314700_dlab052-B83","doi-asserted-by":"crossref","first-page":"m1808","DOI":"10.1136\/bmj.m1808","article-title":"Interpreting a covid-19 test result","volume":"369","author":"Watson","year":"2020","journal-title":"BMJ"},{"key":"2021082617410314700_dlab052-B84","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"; Hornby","year":"2021","journal-title":"N Engl J Med"},{"key":"2021082617410314700_dlab052-B85","year":"2020"},{"key":"2021082617410314700_dlab052-B86","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/microorganisms7080270","article-title":"Novel antibiotics for multidrug-resistant Gram-positive microorganisms","volume":"7","author":"Koulenti","year":"2019","journal-title":"Microorganisms"},{"key":"2021082617410314700_dlab052-B87","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41579-020-0340-0","article-title":"Critical analysis of antibacterial agents in clinical development","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"2021082617410314700_dlab052-B88","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1093\/jac\/dkaa183","article-title":"Oral cephalosporin and \u03b2-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections","volume":"75","author":"Stewart","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2021082617410314700_dlab052-B89","year":"2020"},{"key":"2021082617410314700_dlab052-B90"},{"key":"2021082617410314700_dlab052-B91"},{"key":"2021082617410314700_dlab052-B92","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1021\/acs.jmedchem.9b01976","article-title":"Discovery of cyclic boronic acid QPX7728, an ultrabroad-spectrum inhibitor of serine and metallo-\u03b2-lactamases","volume":"63","author":"Hecker","year":"2020","journal-title":"J Med Chem"},{"key":"2021082617410314700_dlab052-B93","volume-title":"The World Crisis, 1918-1928: The Aftermath","author":"Churchill","year":"1929"},{"key":"2021082617410314700_dlab052-B94","doi-asserted-by":"crossref","first-page":"e00047-19","DOI":"10.1128\/CMR.00047-19","article-title":"Epidemiology of \u03b2-lactamase-producing pathogens","volume":"33","author":"Bush","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"2021082617410314700_dlab052-B95","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/cid\/ciaa122","article-title":"Carbapenem-resistant Enterobacterales, carbapenem resistant organisms, carbapenemase-producing Enterobacterales, and carbapenemase-producing organisms: terminology past its \u201csell-by date\u201d in an era of new antibiotics and regional carbapenemase epidemiology","volume":"71","author":"Livermore","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021082617410314700_dlab052-B96","year":"2020"},{"key":"2021082617410314700_dlab052-B97","year":"2015"},{"key":"2021082617410314700_dlab052-B98","doi-asserted-by":"crossref","first-page":"714","DOI":"10.15585\/mmwr.mm6923e4","article-title":"SARS-CoV-2 infections and serologic responses from a sample of U.S. Navy service members \u2014 USS Theodore Roosevelt, April 2020","volume":"69","author":"Payne","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021082617410314700_dlab052-B99","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/shm\/8.1.55","article-title":"The Russian influenza in the United Kingdom, 1889-1894","volume":"8","author":"Smith","year":"1995","journal-title":"Soc Hist Med"},{"key":"2021082617410314700_dlab052-B100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/shm\/hkq011","article-title":"The Great Dread: cultural and psychological impacts and responses to the \u2018Russian\u2019 influenza in the United Kingdom, 1889-1893","volume":"23","author":"Honigsbaum","year":"2010","journal-title":"Soc Hist Med"},{"key":"2021082617410314700_dlab052-B101","volume-title":"Forgotten Victory","author":"Sheffield","year":"2002"},{"key":"2021082617410314700_dlab052-B102","year":"2020"},{"key":"2021082617410314700_dlab052-B103","volume-title":"Encyclop\u00e6dia Britannica","author":"Schleunes","year":"2020"},{"key":"2021082617410314700_dlab052-B104","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/002200946800300408","article-title":"Problems of the German Revolution 1918-19","volume":"3","author":"R\u00fcrup","year":"1968","journal-title":"J Contemp Hist"},{"key":"2021082617410314700_dlab052-B105","year":"2019"},{"key":"2021082617410314700_dlab052-B106","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/bsp.2009.0729","article-title":"Public health and medical responses to the 1957-58 influenza pandemic","volume":"7","author":"Henderson","year":"2009","journal-title":"Biosecur Bioterror"},{"key":"2021082617410314700_dlab052-B107","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/bsp.2006.4.366","article-title":"Disease mitigation measures in the control of pandemic influenza","volume":"4","author":"Inglesby","year":"2006","journal-title":"Biosecur Bioterror"},{"key":"2021082617410314700_dlab052-B108","article-title":"The cost of the COVID-19 crisis: lockdowns, macroeconomic expectations, and consumer spending","author":"Coibion","year":"2020","journal-title":"National Bureau of Economic Research Working Paper Series"},{"key":"2021082617410314700_dlab052-B109","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1017\/nie.2020.30","article-title":"Living with COVID-19: balancing costs against benefits in the face of the virus","volume":"253","author":"Miles","year":"2020","journal-title":"NIER"},{"key":"2021082617410314700_dlab052-B110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/heartjnl-2020-317912","article-title":"Place and causes of acute cardiovascular mortality during the COVID-19 pandemic","volume":"107","author":"Wu","year":"2021","journal-title":"Heart"},{"key":"2021082617410314700_dlab052-B111","year":"2020"},{"key":"2021082617410314700_dlab052-B112","doi-asserted-by":"crossref","first-page":"625778","DOI":"10.3389\/fpubh.2021.625778","article-title":"COVID-19: rethinking the lockdown groupthink","volume":"9","author":"Joffe","year":"2021","journal-title":"Front Public Health"},{"key":"2021082617410314700_dlab052-B113","year":"2011"},{"key":"2021082617410314700_dlab052-B114","year":"2020"},{"key":"2021082617410314700_dlab052-B115","year":"2020"},{"key":"2021082617410314700_dlab052-B116","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(20)31750-5","article-title":"Lebanon faces humanitarian emergency after blast","volume":"396","author":"Devi","year":"2020","journal-title":"Lancet"},{"key":"2021082617410314700_dlab052-B117","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10096-015-2520-9","article-title":"Detection and characterization of carbapenemase-producing Enterobacteriaceae in wounded Syrian patients admitted to hospitals in northern Israel","volume":"35","author":"Lerner","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021082617410314700_dlab052-B118","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/mdr.2012.0219","article-title":"OXA-48 carbapenemase-producing Klebsiella pneumoniae isolated from Libyan patients","volume":"19","author":"Lafeuille","year":"2013","journal-title":"Microb Drug Resist"},{"key":"2021082617410314700_dlab052-B119","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1590\/S1020-49892010000300009","article-title":"Trends in antibiotic utilization in eight Latin American countries, 1997-2007","volume":"27","author":"Wirtz","year":"2010","journal-title":"Rev Panam Salud Publica"},{"key":"2021082617410314700_dlab052-B120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-9560-3-22","article-title":"Socio economic crisis and mortality. Epidemiological testimony of the financial collapse of Argentina","volume":"3","author":"Gurfinkel","year":"2005","journal-title":"Thromb J"},{"key":"2021082617410314700_dlab052-B121","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijid.2005.05.012","article-title":"Does a reduction in antibiotic consumption always represent a favorable outcome from an intervention program on prescribing practice?","volume":"10","author":"Bantar","year":"2006","journal-title":"Int J Infect Dis"},{"key":"2021082617410314700_dlab052-B122","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"2021082617410314700_dlab052-B123","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"2021082617410314700_dlab052-B124","year":"2020"},{"key":"2021082617410314700_dlab052-B125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"2021082617410314700_dlab052-B126","year":"2020"},{"key":"2021082617410314700_dlab052-B127","year":"2021"},{"key":"2021082617410314700_dlab052-B128","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/jac\/dkw374","article-title":"Efficacy of ceftolozane\/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials","volume":"72","author":"Popejoy","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2021082617410314700_dlab052-B129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s15010-018-1133-5","article-title":"Ceftolozane\/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections","volume":"46","author":"Escol\u00e0-Verg\u00e9","year":"2018","journal-title":"Infection"},{"key":"2021082617410314700_dlab052-B130","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1473-3099(16)30004-4","article-title":"Ceftazidime\/avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study","volume":"16","author":"Carmeli","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2021082617410314700_dlab052-B131","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/cix783","article-title":"Colistin versus ceftazidime\/avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae","volume":"66","author":"van Duin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2021082617410314700_dlab052-B132","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1093\/jac\/dky295","article-title":"Effectiveness of ceftazidime\/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae","volume":"73","author":"Sousa","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2021082617410314700_dlab052-B133","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40121-018-0214-1","article-title":"Effect and safety of meropenem\/vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO II randomized clinical trial","volume":"7","author":"Wunderink","year":"2018","journal-title":"Infect Dis Ther"},{"key":"2021082617410314700_dlab052-B134","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/cid\/ciz530","article-title":"RESTORE-IMI 1: a multicenter, randomized, double-blind trial comparing efficacy and safety of imipenem\/relebactam vs colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections","volume":"70","author":"Motsch","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021082617410314700_dlab052-B135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jac\/dkq408","article-title":"Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates","volume":"66","author":"Livermore","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2021082617410314700_dlab052-B136","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/phar.2366","article-title":"Evaluation of eravacycline: a novel fluorocycline","volume":"40","author":"Alosaimy","year":"2020","journal-title":"Pharmacotherapy"},{"key":"2021082617410314700_dlab052-B137","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2021082617410314700_dlab052-B138","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1099\/acmi.fis2019.po0008","article-title":"In-vitro activity of cefiderocol against multidrug-resistant Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii isolates from the UK","volume":"2","author":"Mushtaq","year":"2020","journal-title":"Access Microbiol"},{"key":"2021082617410314700_dlab052-B139","year":"2019"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jacamr\/article-pdf\/3\/Supplement_1\/i5\/39990390\/dlab052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jacamr\/article-pdf\/3\/Supplement_1\/i5\/39990390\/dlab052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T17:43:36Z","timestamp":1629999816000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/3\/Supplement_1\/i5\/6299850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":139,"journal-issue":{"issue":"Supplement_1","published-print":{"date-parts":[[2021,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlab052","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,6,1]]}}}